Liuwei Dihuang Decoction improves cognitive impairments via regulating immune system in APP/PS1 transgenic mouse,a mouse model of Alzheimer disease

被引:0
|
作者
Xi LEI [1 ]
Jian-hui WANG [1 ]
Xiao-rui CHENG [1 ]
Xiao-rui ZHANG [1 ]
Gang LIU [1 ]
Jun-ping CHENG [1 ]
Wen-xia ZHOU [1 ]
Yong-xiang ZHANG [1 ]
机构
[1] Beijing Institute of Pharmacology and Toxicology,State Key Laboratory of Toxicology and Medical Countermeasures
关键词
Liuwei Dihuang Decoction; Alzheimer disease; PrP-hAβPPswe/PS1ΔE9 transgenic mouse; learning and memory; immune;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
摘要
OBJECTIVE To investigate the effect and mechanisms of Liuwei Dihuang Decoction(LW) on cognition in PrP-hAβPPswe/PS1ΔE9(APP/PS1) transgenic mice.METHODS LW was adminis.trated with oral for 3 months.The locomotor activity test was performed to investigate the spontaneous motor activity of mice.The Morris water maze test and shuttle box test were performed to investigate the spatial learning and memory and active avoidance response respectively.The Αβ deposits and neuron loss in the hippocampus was detected by immunofluorescence staining and nissl staining respectively.The flow cytometry was employed to investigate the lymphocyte subsets of the mice.The 3 H-thymidine incorporation was performed to investigate the splenocytes proliferation.RESULTS The treatment of LW ameliorated the impairments of spatial learning and memory and active and passive avoidance in APP/PS1 mice.The administration of LW alleviated neuron loss in the brain,suppressed amyloid-β(Αβ) deposits in the hippocampus of APP/PS1 mice.The treatment of LW significantly increased ConAand LPS-induced proliferation of splenocytes,increased CD3+ T cells and CD19+ B cells in the spleen lymphocytes and reduced Gr1+ cells in APP/PS1 mice.CONCLUSION This data indicated the adminis.tration of LW ameliorated behavioral and pathological deterioration via regulating immune function.
引用
收藏
页码:291 / 291
页数:1
相关论文
共 50 条
  • [21] ADAM17 overexpression improves cerebrovascular vasoreactivity and cognitive function in the APP/PS1 mouse model of Alzheimer's disease
    Fopiano, Katie Anne
    Tian, Yanna
    Suggs, Hayden
    Buncha, Vadym
    Lang, Liwei
    Wang, Rongrong
    Filosa, Jessica
    Bagi, Zsolt
    PHYSIOLOGY, 2023, 38
  • [22] Daphnetin improves cognitive function in an APP/PS1 doubletransgenic mouse model of Alzheimer's disease by inhibiting Aß deposition and astrocytic activation
    Gao, P.
    Wang, Z.
    Lei, M.
    Liu, J.
    Noda, M.
    Peng, Y.
    Long, J.
    GLIA, 2023, 71 : E696 - E696
  • [23] Dysregulation of Histone Acetylation in the APP/PS1 Mouse Model of Alzheimer's Disease
    Francis, Yitshak I.
    Fa, Mauro
    Ashraf, Haider
    Zhang, Hong
    Staniszewski, Agnieszka
    Latchman, David S.
    Arancio, Ottavio
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (01) : 131 - 139
  • [24] Vascular and metabolic dysfunctions in APP/PS1 mouse model of Alzheimer's disease
    Iordanova, B.
    Fukuda, M.
    Klunk, W.
    Vazquez, A. L.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 44 - 45
  • [25] Mechanical alterations of the hippocampus in the APP/PS1 Alzheimer's disease mouse model
    Antonovaite, Nelda
    Hulshof, Lianne A.
    Huffels, Christiaan F. M.
    Hol, Elly M.
    Wadman, Wytse J.
    Iannuzzi, Davide
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2021, 122
  • [26] The neuroprotective effects of Liuwei Dihuang medicine in the APP/PS1 mouse model are dependent on the PI3K/Akt signaling pathway
    Yuan, Ye
    Liu, Yamei
    Hao, Li
    Ma, Jinlian
    Shao, Simai
    Yu, Ziyang
    Shi, Ming
    Zhang, Zhenqiang
    Zhang, Zijuan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [27] Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease
    Pugh, Perdita L.
    Richardson, Jill C.
    Bate, Simon T.
    Upton, Neil
    Sunter, David
    BEHAVIOURAL BRAIN RESEARCH, 2007, 178 (01) : 18 - 28
  • [28] Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer’s disease mouse model by regulating the expression of APP secretases
    Miaomiao Zhang
    Wanyao Wang
    Qun Ye
    Yun Fu
    Xuemin Li
    Ke Yang
    Fan Gao
    An Zhou
    Yonghui Wei
    Shuang Tian
    Shen Li
    Fengjiang Wei
    Wentao Shi
    Wei-Dong Li
    Alzheimer's Research & Therapy, 16
  • [29] Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer's disease mouse model by regulating the expression of APP secretases
    Zhang, Miaomiao
    Wang, Wanyao
    Ye, Qun
    Fu, Yun
    Li, Xuemin
    Yang, Ke
    Gao, Fan
    Zhou, An
    Wei, Yonghui
    Tian, Shuang
    Li, Shen
    Wei, Fengjiang
    Shi, Wentao
    Li, Wei-Dong
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [30] The hypothalamus as the primary brain region of metabolic abnormalities in APP/PS1 transgenic mouse model of Alzheimer's disease
    Zheng, Hong
    Zhou, Qi
    Du, Yao
    Li, Chen
    Xu, Pengtao
    Lin, Li
    Xiao, Jian
    Gao, Hongchang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (01): : 263 - 273